Welcome to CMEZone

CMEZone.com is a full-service web solution that provides timely, practical, and clinically relevant continuing education for health care professionals. All CMEZone activities are designed to enhance clinical knowledge and competence and to improve patient care.

More than 100,000 health care professionals maintain membership in CMEZone in order to access continuing education activities on demand. All activities are easily accessible, free of charge and offer participants instantaneous post-test grading and printable certificates of completion.

CMEZone is operated by Applied Clinical Education (ACE). As an advocate of lifelong learning and supporter of applied learning strategies, ACE is dedicated to providing education that strengthens performance and enhances the clinical care of patients.

Participant Login


Remember Me
Lost your password? New user? Register here
Chronic Lymphocytic Leukemia: Updates and Important Unanswered Questions
Credits: 0.5 Accreditation: ACCME
Expires: October 13, 2016
Breast Cancer: ASCO 2015 Review
Credits: 0.5 Accreditation: ACCME
Expires: October 13, 2016
Lung Cancer
Credits: 0.5 Accreditation: ACCME
Expires: October 13, 2016
B-Cell Non-Hodgkin Lymphomas
Credits: 0.5 Accreditation: ACCME
Expires: October 13, 2016
Credits: 1 Accreditation: ACCME
Expires: October 18, 2016
Gynecologic Oncology
Credits: 0.5 Accreditation: ACCME
Expires: November 4, 2016
Hodgkin Lymphoma & Lymphoplasmacytic Lymphoma
Credits: 0.5 Accreditation: ACCME
Expires: November 4, 2016
Multiple Myeloma & Evolving Role of Transplant
Credits: 0.5 Accreditation: ACCME
Expires: November 4, 2016
Colorectal Cancer
Credits: 0.5 Accreditation: ACCME
Expires: November 4, 2016
Credits: 1.25 Accreditation: ACCME
Expires: December 1, 2016
Credits: 1 Accreditation: ACCME
Expires: December 1, 2016
Credits: 1 Accreditation: ACCME
Expires: January 13, 2017
Credits: 1 Accreditation: ACCME
Expires: January 16, 2017
Credits: 1 Accreditation: ACCME
Expires: March 8, 2017
Part 1: Screening and Diagnosis
Credits: 0.75 Accreditation: ACCME
Expires: June 7, 2017
Part 2: Driver Mutations in Adenocarcinoma
Credits: 0.5 Accreditation: ACCME
Expires: June 7, 2017
Part 3: Squamous Cell Disease
Credits: 0.5 Accreditation: ACCME
Expires: June 7, 2017
Credits: 1 Accreditation: ACCME
Expires: February 16, 2017

You thought this day would never come. When you walked into your hospital as an intern five, six, seven or more years ago, it seemed inconceivable that you woul...

 The test is approved as a blood-based companion diagnostic for the cancer drug erlotinib. This is the firs...

Clinicians should warn patients about the risk for serious bleeding when using over-the-counter antacids containing aspirin, according to the FDA. Recent data regarding increased risk for heart attack or stroke have led the FDA to mandate nonsteroidal anti-inflammatory drug label updates that reflect these... This report provides an overview of antibiotic resistance in Gram-negative enteric organisms, with a particular focus on carbapenem resistance in Klebsiella pne... The overall goal of the 90-90-90 program is achieving viral suppression among 73% of HIV-infected individuals worldwide by 2020, a marked improvement from c... Researchers wanted to determine whether beam steering will improve visibility when used with echogenic and nonechogenic needles for moderate angles of insertion...